May 28, 2019
Spectrum Announces Poziotinib ZENITH20 Trial HER2 Cohort (Cohort 2) Has Reached Enrollment Target
Enrollment of cohort 2 was completed six months ahead of schedule Cohort 2 had a target enrollment of 87 NSCLC…
Pharmaceuticals, Biotechnology and Life Sciences
Enrollment of cohort 2 was completed six months ahead of schedule Cohort 2 had a target enrollment of 87 NSCLC…
Partnership accelerates access to inebilizumab in China and supports the mission of both companies to bring transformative therapies to more…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement…
DUBLIN–(BUSINESS WIRE)–The “Nasopharyngeal Cancer – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Nasopharyngeal Cancer –…
DUBLIN–(BUSINESS WIRE)–The “Osteosarcoma – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Osteosarcoma – Pipeline Review,…
DUBLIN–(BUSINESS WIRE)–The “Osteoarthritis – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Osteoarthritis – Pipeline Review,…
DUBLIN–(BUSINESS WIRE)–The “Diabetic Macular Edema – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Diabetic Macular…
DUBLIN–(BUSINESS WIRE)–The “Sepsis – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Sepsis – Pipeline Review,…
The company is commercializing its FDA-cleared bio-ConneKt® Wound Matrix to the advance wound care market. ALACHUA, Fla.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/MLMBiologics?src=hash" target="_blank"gt;#MLMBiologicslt;/agt;–UF…
Represents the Fourth Innovus Pharma Product Notification in the E.U. SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”)…